Inositol for Mood Support

Research suggests that inositol — particularly in its myo-inositol form — plays a measurable role in brain signaling pathways that are relevant to mood regulation, though the studies provided do not directly test inositol supplementation for mood outcomes. The most directly relevant finding comes from mechanistic research showing that lithium, a well-established mood stabilizer, exerts some of its therapeutic effects by inhibiting IMPA1, an enzyme involved in recycling inositol within brain cells, which in turn dampens overactive neural signaling — lending indirect support to the idea that inositol-related pathways matter for mood. A separate neuroimaging study found that myo-inositol levels in the prefrontal cortex were associated with white matter abnormalities in people with early psychosis, suggesting this compound may serve as a marker of glial cell activity in mood-relevant brain regions, though this does not establish a therapeutic role for inositol supplementation. Taken together, the available evidence here is largely mechanistic, observational, or tangentially related rather than drawn from controlled clinical trials of inositol as a mood supplement, so firm conclusions about its effectiveness for mood support cannot be drawn from this set of studies alone.